Budget 2023Budget 2023


  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
Budget 2023
Budget 2023
you are here: HomeNewsOpinion

Gland Pharma’s focus on injectables yields superior growth

Gland Pharma’s revenue growth surpassed that of frontline drug companies in FY21. It is expected to outpace industry majors in the current fiscal too

May 21, 2021 / 08:59 AM IST
Gland Pharma’s focus on injectables yields superior growth

Deep focus helps. When asked why Dr Reddy’s Laboratories launched an injection to treat infections in partnership with Gland Pharma, despite having invested in injectable capacities itself, G V Prasad, co-chairman and managing director of Dr Reddy’s, said: “I think the penems require dedicated facilities, which we don’t have and Gland Pharma has dedicated a line to penems so we are using that capacity.” That in a way underscores the importance of Gland Pharma. It is a vertically integrated injectable-focused...

To read the full story, Subscribe to Moneycontrol PRO

Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

Already a member? Sign in

Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

50% OFF

What Do You Get

  • Ad free experience

    Experience a non-intrusive navigation and faster response in the ad free mode

  • Sharpest Opinions

    Access to 230+ exclusive stories per month from our editorial and Experts

  • +

    Have a Global edge with access to content from world renowned experts and journalist

  • Actionable Insights

    Access to 40+ weekly investment ideas including 4 daily technical calls

  • Virtual Events

    Exclusive access to live webinars from market experts on trading and investment strategies

  • Newsletters

    Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

Get upto 50% discount on limited period offers